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Abstract
Binuclear rhodium(ll) complexes [RhCI(I-OOCR)2(N-N)2], [Rh(I-OOCR)(N-N)(H20)2](RCOO)2
and [Rh2CI2(#-OOCCH3)(terpy)2](H30-)CF2.9H20 (R H, Me, Bun,-ph, PhCHOH; N-R 2,2-bipyridine
(bpy), 1,10-phenanthroline (phen), 2,9-c]ime-thyl-l,10-phenanthroline (dmp) and 6,7-dimethyl-2,3-
di(2-pyridyl)quinoxaline (dmpq); terpy 2,2’:6’,2"-terpyridine) have been synthesized and their
structure and properties have been studied by electronic, IR and H NMR spectroscopy.
Antibacterial activity of these complexes against Staphylococcus aureus and Escherichia coil has
been investigated. The most active antibacterial agents against S. aureus were
[Rh(OOCPh)2(phen)(HO)]2+, [R_h2(OOCPh)2(dmpq)e(H20)2]2+, [Rh2(OOCBu)2(phen)2(H20)].
2+
and-[Rh-(OOCBu)2(bpy-)(FI20)]z+ which were considerably more active than the appropnae
nitrogen ]igands. The complexes show rather low activity against E. coli.
Introduction
Binuclear rhodium(ll) tetracarboxylato complexes [Rh(OOCR)4L] as well as complexes containing
two bridging ligands [Rh2X2(OOCR)2(N-N)2 and [Rh(-OOCR)2(N--N)2L]2+, where L Lewis base, X
halide and N-N 2,2’-bipyridine, 1,1-0-phenanhroline and tl’ie=’ derivatives have aroused
considerable interest because of interesting structure and reactivity [1-3], catalytic properties [1,4]
and anticancer activity [1,2,5]. We have prepared and investigated the structure, reactivity, catalytic
2+ activity and cytostatic activity of [Rh2X2(OOCR)2(N-N)2 and [Rh2(OOCR)2(N-N)2(H20) complexes
(R H, Me, PhCHOH, N-N 2,2’-bipyridine, 1,10-phenant-hroline and their derivatives [2,4].
Rhodium(ll) carboxylato complexes belong to the most promising platinum metals compounds
having anti-cancer and biological activity [5-7]. These compounds were shown to increase the
lifespan of tumor bearing mice and in favorable cases to produce complete regression of the tumor
[8-11]. This discovery has prompted investigations into the chemical properties and biological
effects of these complexes [1,5,6,10-15]. The antitumor activity .of Rh.(OOCR)4 complexes
intensified studies of their interaction with biomolecules, e.g. am=noac(]s, peptides, vitamins,
nucleic acid bases, adenosine phosphates, DNA, etc. [1,5,6,8-15]. Tetraacetatodirhodium(ll) binds
effectively to human serum albumin via imidazole rings leading to the conformational changes of
HSA [15]. The binuclear rhodium(ll) carboxylates, like cis-[PtCI2(NH3)2], appear to increase biological
activity induced by irradiation [16-17].
Recently it has been found [18] that [Rh2(OOCR)2(N-N)2 0)2 complexes show
cytostatic activity for human oral carcinoma KB cell-line in vitro. Some the determined biological
activities were in close relation with findings obtained on plant cell cultures [19], when
synchronously cultivated green algae were exposed to Rh(ll) complexes. New metal compounds
possessing antimicrobial activity are recently intensively investigated because of the increasing
resistance of microbes against many antibiotics. It has been found that some platinum complexes
possessing antitumor activity show also antibacterial properties. A further well defined series of
metal complexes with antibacterial activity is that of rhodium(Ill) coordination compounds of formula
trans-[RhX2(py)4]Y [20-22]. These complexes are more active against Gram-positive microorganisms
than Gram-negative ones. However, the complexes [RhCI2(bpy)2]
/ are not active antibacterial
agents. There is considerable interest in interactions of tetra-#-carboxylato-dirhodium(ll) complexes
with nucleic acid bases because they function as antitumor agents against many types of tumors by
inhibiting DNA or protein synthesis. The examination of the biological activity of these compounds
in such living systems (i.e. tumor bearing animals) is time consuming and expensive and should be
used at the last step of examination. The exposure of mammalian cells in cultures or microorganisms
cultivated synchronously, or an examination of the antibacterial activity of metal compounds [19,23]
give also interesting information about the general biological activity of the tested compounds. In
this paper, we report on synthesis and properties of dimeric rhodium(ll) complexes with carboxylato
and heterocyclic nitrogen ligands and their antibacterial activity.
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Experimental
Synthesis of the complexes.
Complexes [Rh (OOCCH) (H O) [24], Nan[Rh (CO)4].2.5H O [25], [Rh-{OOCC-
H(OH)Ph}4(H20)t [2], [Rh2{CH(2OH)eh}(phenf(H2)](OO-CH(OH)ehl2 (2)[18],
[RhCI{OOCCH(OH)Ph}-(phen)] (3)[2], [Rh2(OOCFI)2(bpy)CI2].4H20 (8)-[2], and
[Rh2-(OOCCH)(terpy)2CI2][H30]CI2.9H2-O (9) [26] were prepared 15y literaIure methods.
1,10-Phenanthroline (phen), 2,9-dimethyl-l,10-phenanthroline (dmp), 2,2’-bipyridine
(bpy), 2,2’:6’,2"-terpyridine (terpy) and 6,7-dimethyl-2,3-bis(2-pyridyl)quinoxaline (dmpq) were
obtained from Aldrich and used without further purification.
[Rh,,2(OOCCHOHPh)(.1269(dmP)2(H20)2](OOCCHOHPh)2(1).
A solution of
[Rh2(OOCH-OHPh)4(H20)2 g, 0.15 mmol) and dmp (0.0625 g, 0.3 mmol) in 6 cm3 of
ethanol was heated at reflux with stirring for 2 h. The initial green colour of the solution was soon
replaced by brown-red and then by deep green-blue. The deep green-blue rhodium (I) complexes
are formed because rhodium(ll) dimers are reduced by ethanol. However, rhodium(I) compounds
are very readily oxidized to red-brown dimeric rhodium(ll) complexes under an atmosphere of air.
After cooling in air atmosphere, the brown-red solution was filtered and the filtrate was treated with
diethyl ether to produce a brown solid.The sample was collected by filtration in air, washed with
diethyl ether, and dried in vacuo; yield 0.104 g, 55%. Anal. Calc. for C6oH56N4014Rh2: C, 57.06; H,
4.47; N, 4.44. Found: C, 56.45; H, 3.91: N, 3.97.
[Rh2(OOCCH)2(dmpq)2(H20)2](OOCCH3)2.2H20 (4). A solution of
[Rh2(OOCCI-3)4(H20)2] (0.0956 g, 0.2 mmol) and (:lmpq (0.125 g, 0.4 retool) in 7 cm3 of ethanol was
heated under reflux for 5 h, cooled to the room temperature and, after filtration in air, concentrated
to approximately 2 cm3.The product was deposited with diethyl ether. The dark brown precipitate
was filtered off, washed with diethyl ether and dried in vacuo, yield .0.1456 g, 64 %. Anal. Calc. for
C48H52NBO12Rh2: C, 50,63; H, 4.60; N, 9.84. Found: C, 49.96; H, 4.37: N, 9.54.
[Rh2(OOCPh)2(phen)(H20)2](OOCPh) (5). A mixture_of [Rh2-(OOCPh)4(H20)2
3 (0.1089 g, 0.15 mmol) and phen (-0.0594 g, 0.3 mmol)-in ethanol (Scm) was heated under reflux for
3 h and filtrated under air atmosphere. Addition of diethyl ether to the reaction solution produces a
brown-red precipitate. The product was washed with diethyl ether and dried in vacuo, yield 0.1674
g, 77%. Anal. Calc. for C52H4oN4OloRh2: C, 57.47; H, 3.71; N, 5.16. Found: C,56.91; H, 4.14: N,
5.33.
[Rh2(OOCCH3)2{OOCCH(OH)Ph}2 (6)A solution of [Rh2(OOC-CH3),(HO)2 (0.221
g, 0.5 mmol) and (S)-mandelic acid (0.152 g, mmol) was heated under reflux for 24 h.-The solution
was evaporated and green compound was dried in vacuo at 100 C for 5 h, yield 0.251 g, 80 %.
Anal. Calc. forC H.,oO,oRh.,: C, 38.36; H, 3.22; Found: C,38.00; H, 3.39.
[Rh2(H21:baa(l’:J20)2 (7). A mixture of Na4[Rh2(CO3)4].2.5H20 (0.0583 g, 0.1 mmol) and
0.5 cm3 of 1- M H3PO4 in water (5 cm3) was heated for 1 15, concentrated to approximately half
volume. The green powder was collected, washed with methanol and dried in vacuo, yield 0.0481
g, 67%. Anal. Calc.: Rh, 32.68; P, 19.67. Found: Rh, 31.8; P, 19.9.
[Rh2(OOCPr)(bpy)(H20)2](OOCPr)2 (10)A mixture of [Rh(OOCPr)4 (0.111 g, 0.2
3 mmol) and 1spy (0.0624 g, 0.4-mmol) in 1,4-dioxane (5 cm was heatec3 under reflux for 2 h. The
red-brown precipitate was collected, washed with dioxane and dried in vacuo, yield 0.123 g, 68 %.
Anal. Calc. for C.6H,BN,OloRh2: C, 47.91; H, 5.36; N, 6.21. Found: C, 47.54, H, 5.12, N, 5.88.
[Rh2(OOCBun)2(-phen)2(H20)](OOCBun)2 (11) The procedure was analogous to
that used for the previous preparation. Starting with 0.122 g (0.2 mmol) of [Rh2(OOCBun).4] and
0.0792 g (0.4 mmol) of 1,10-phenanthroline hydrate, red-brown complex 11 was obtained (0.143
g, 71% yield). Anal. Calc. for C44H56N40oRh2: C, 52.49; H, 5.61; N, 5.57. Found: C, 52.82; H,
5.40; N, 5.69.
[Rh2(OOCBun)2(bpy)2(H20)2](OOCBun)2 (12)This complex was obtained according
to the procedure used for the preparation of complex 10, starting with 0.122 g (0.2 mmol) of
[Rh2(OOCBun)4] and 0.0624 g (0.4 mmol) of bpy. Yield 0.146 g, 76 %. Anal. Calc. for
C4oH56N_40_1oRh2: C, 50.11; H, 5.89; N, 5.84. Found: C, 50.35; H, 5.45; N, 5.95.
[Rh{OOCCH(OH)Ph}2(bpy)2(H20)2](OO,CCH(OH)Ph):, (13). A solution of
[Rh2{OOCCH(OH)Ph}n(HO)2 (0.423 g, 0.5 retool) and 2,2-bipyridine (0.15E g 1 retool) in 5 cm3 of
ethanol was heated at rellux for 2 h, cooled to the room temperature and filtered in air. From the
filtrate the dark red product was deposited by means of diethyl ether. Precipitate was filtered off,
washed with (C2H5)O and dried under reduced pressure, yield 0.376 g, 65%. Anal. Calc. for
C52H48N_404Rh2: C 53.90, H 4.18, N 4.83. Found: C 53.40, H 4.07, N 4.94.
[Rh(OOCPr),,] (14). A mixture of Na,t[Rh(CO3)a].2.SH20 (0.583 g, 1 retool) and
CH3CH2CH2COOH (0.73 cm3, 8 retool) in water (10 cm3) was heated for 2 h. After cooling the green
precipitate was filtered off, washed with water and dried in vacuo, yield 0.458 g, 92 %. Anal. Calc for
C16H2808Rh2: C, 34.68; H, 5.09. Found: C, 34.28; H, 4.92.
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[Rh2(OOCBun) (15). The procedure was analogous to that used for the previous
preparation. Starting with 0.583 g (1 mmol) of Na4[Rh2(CO3)4].2.5H20 and 0.87 cm3 of C4H9COOH,
green precipitate (0.555 g, 91% yield) of tetra--pentanoato-dirhodum(ll) was obtained. Anal. Calc
for C2oH6OsRh.,: C, 39.36; H, 5.95. Found: C, 38.95; H, 5.86.
[Rh2(OCPh)4(HgO)2 (16). A mixture of Na4[Rh2(CO)4].2.5H20 (0.583 g, 1 mmol) and
PhCOOH (0.977 g, 8 mmoD in 15 cm3 of wate_ was heated-for h. The yellow-green precipitate was
collected, washed with hot water 5 x 15 cm3) and dried in vacuo. Anal. Calc. for 028H2401oRh2: C,
46.30; H, 3.33; Found: C,46.37; H, 3.08.
Physical measurement.
Infrared spectra (KBr pellets and nujol mulls) were measured on a Perkin Elmer 283 and a
Bruker IFS 113v, UV-VIS on a Cary 5 and Beckman DU 7500, and H NMR spectra on a Bruker AMX
300.
Antibacterial activity.
The antibacterial activity was evaluated in vitro according to the standard methods [27] on
reference strains Staphylococcus aureus 209P (Oxford) and clinical isolates of S. aureus obtained
from Bacteriological Laboratory of Kaminski’s Hospital.The preliminary experiments were performed
on overnight broth culture of the bacteria. Minimal inhibitory concentration (MIC) was determined by
plating 0.1 cm3 of broth cultures, suitably diluted in saline, on nutrient agar plates supplemented
with tested compounds of different concentration. The cultures were diluted to obtain the samples
spread on the control plates (without rhodium compound) containing about 100 colony forming
units. Activity of the compounds was also tested in liquid YP medium (yeast axtract Difco 1%,
pepton Bacto 1%, NaCI 0.5%). In these tests the media containing rhodium complexes were
inoculated with 103 or 106 colony forming units and viable count was determined at suitable
intervals. The turbidity at 560 nm was determined after 24 h and 48 h. Survival of the bacteria was
also tested in saline containing different concentration of the compounds.
Results and Discussion
The [Rh2(RCOO)2(N-N)2(HO)][RCOO]2 complexes were prepared by reactions between
[Rh2(RCOO)4(H20)2 and appropriafe nitrogen ligand.
They are stable under air atmosphere both in solid state and in solutions, readily soluble in
water, methanol and ethanol and slightly soluble in higher alcohols, insoluble in diethyl ether and
nonpolar solvents. Primary and secondary alcohols at elevated temperatures reduce these
complexes giving rhodium(I) complexes, that are very readily reoxidized to rhodium(ll) compounds
by means of air.
All complexes have been characterized by a combination of elemental analysis and IR, UV-
VIS and H NMR spectroscopy. The data are collected in Tables 1-3.
The physicochemical measurements indicate that structure of the cationic complexes
containing two bridging carboxylato ligands is analogous to that of Rh2CI2(RCOO)2(N-N)2 [2,4] (Fig.
1) with water molecules coordinating along Rh-Rh axis.
H20 _OO jR
/Rh I’C\
NOH2_
2+ R
LRh"O?..C
R
O. O/ L
o
Fig. 1. Structure of [Rh2(OOCR)2(N-N)2(H20)2]2+ and [Rh2(OOCR)4L2] complexes.
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Table 1. Electronic Spectra of Rhodium(ll) Complexes.
Complex*
1
4
5
12
13
"Band, X(e), [nm](M4cm4)
.560i’450)sh 460(2100)sh, 361(6300)sh, ’272’(34300), 2’2’5(67700).’
588/900)sh, 475(2800)sh.,378(14400), 278(42300).
559(160), 411 (1600)sh, 363(2800)sh, 334(4400)sh, 271 (29600),
250(48400)sh, 231{68000)
587(2!.0), 451(100),415(75)sh 340(150)sh, 252(5600), 21’8(20300)..
666(120)., 467..(70)sh, 400(95), 290(470)sh, 246(16300)
563(240), 415(2000), 360(3400)sh., 305(15300), 272(27200)sh, 257(30500)
568(370), 411(2450)s..h...,. 332(5500), 272(32200), 254(36800), 228(45800).
559(290), 415.(2350), 360(4100)sh, 301 (17900)sh, 271 (31800)sh,
565(230), 412(2100), 355(3200)sh, 312(1660.0).sh, 302(18800), 253(32800)
solutions in H20
In the electronic spectra (Table 1) of these complexes in the visible region two bands are observed.
Band occurs at about 560-568 nm, about 20-30 nm lower compared with that for
[Rh(RCOO)4(H20) compounds. This shift may be explained by assuming that band corresponds
to te rt*(Rh)--->’-(Rh2) transition, since the rr.*(Rh2)levels in [Rh(RCOO)(N-N)2(HO)2]
2+
complexes, due to the interaction of the orbitals of the-Rh2 core with t’-orbitals of nitrogen Ifgands,
have lower energy than that of the r*(Rh2)(5eg orbita!s in [Rh2(OOCR)4(H20)2 comPounds. The
intense band II at about 410-470 nm was assigned to the allowed charge-transfer transition
(Rh2)--->rt*(N-N [28]. This band obscures the absorption of low intensity attributed to the
rt*(Rh2)--->*(Rh-O transition observed at 430-450 nm in [Rh2(OOCR)4(H20)2 complexes. The
energy of the band strongly depends on the nature of axial ligands and increases with increasing
of the field strength of these ligands. Band remains relatively constant for axial oxygen donor
ligands, bt is blue shifted with nitrogen or sulfur donor ligand. Electronic spectra of
[Rh2(RCOO)2(N-N)2(H20)2](RC00)2 in ethanol in the presence of adenine for molar ratios
Rh2:adenine of 1:1 and 1:2 show that 5and is blue shifted for about 10-40 nm. This indicate that
adenine is coordinating to rhodium via nitrogen atom. However, in the case of adenosine blue shift
is much lower (ca. 2-5 nm) suggesting that this ligand is coordinating through oxygen atom or
undergoes stacking owing to the r interaction between the purine moiety and a heteroaromatic
amine bound with rhodium atom. The stacking of nucleobases and metal complexes is well known
[29-31].
Table 2. IR Spectra of Rhodium(ll) Compounds.
Complex VCH
[cm4
3080vw, 3055m,
3025m, 3000vw,
2970vw, 2915vw,
2840vw
3090w, 3062w,
3027w
3126, 3672vw,
2978w, 2925w,
2858w
vaSCoO
[cm4
1588vs,
1575sh,
1550sh
1610vs,
1575vs
1571vs
VScoo
[cm-]
1405sh,
1393vs,
1373s,
1350vs
1428vs,
1410vs,
1400sh,
1360sh,
1338vs,
1325sh
1445vs,
1412vs
other bands
[cm4
1527vw, 1498wm, 1480m, 1440m,
1292vw, 1285vw, 1232vw, 121 ow,
1200vw, 1180m, 1160sh, 1138mw,
1100sh, 1078m, 1052s, 1018mw, 988vw,
973vw, 947m, 918w, 854s, 790m, 745s,
735s, 700s, 667mw, 637m, 560w, 545m,
470vw, 435w, 392wm
1513m, 1489m, 1448s, 1’220, "’1"’205vw,
1187m, 1143w, 1110sh, 1087m, 1053s,
1023m, 997vw, 948vw, 928m, 898vw,
880vw, 840s, 782w, 735vs, 711vs, 696vs,
653vw, 644w, 612w, 558vw, 510vw,
470vw, 433vw
1624m, ’1477S, 1362s, 1329w, 1287w,
1215w, 1187w, 1164w, 1089m, 1051 w,
999m, 875m, 801w, 776m, 756m, 707m,
654w, 631vw, 619vw, 573w, 388vw, 365w,
351vw, 333w
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10
11
12
13
14
15
16
3080vw, 3060w,
3040vw, 3015vw,
2920vw, 2855vw
3090vw, 3065w,
3047vw, 3035w,
3010vw, 2930w,
2860vw
3105vw, 3075wm,
3038w, 2990vw,
2925w, 2855 vw
31 lovw, 3078w,
3050w, 3020vw,
2960s, 2935w,
2885
3058w, 2967s,
2940s, 2880m,
2870m, 2090vw
3120vw, 3090vw,
3077w, 3043w,
2970s, 2944s,
2880
3117w, 3085w,
3057w, 3030w,
2927vw
2985s, 2935m,
2877m
2983s, 2940s,
2880m
3100vw, 3080vw,
3060w, 2920w,
2850w
1592vs,
1542vs
1592vs,
1580vs
1545vs
1605m,
1580sh,
1562vs,
1557vs
1590vs,
1558
1605sh,
1587vs,
1565vs
1620sh,
1605vs,
1574vs
1570vs
1570vs
1552vs
1427s,
1410vs,
1355sh,
1340vs
1450sh,
1435sh,
1413vs
1447vs
1462s,
1447s,
1430,
1418vs,
1377s
1455sh,
1431vs,
1420vs,
1370s
1470s,
1453s,
1431vs,
1420
1420sh,
1404vs,
1335vs,
1327vs,
1310sh
1460s,
1427vs,
1410vs,
1380w
1446m,
1430s,
1413vs
1398vs
1512m, 1492w, 1380w, 1297vw, 1220vw,
1204vw, 1168w, 1142w, 1124vw, 1108vw,
1064w, 1020m, 850m, 838s, 810vw,
766vw, 720vs, 710vs, 692s, 668m, 612vw,
502m, 433vw, 400vw, 385vw, 357vw,
327vw
1645w, 1522w, 1490w, 1370w, 1349w,
1280w, 1227w, 1184m, 1082m, 1060s,
1045sh, 1023m, 998vw, 945w, 918vw,
850w, 837vw, 782w, 750m, 694vs, 633m,
593vw, 561w, 485w, 376m, 337m
1601s, 1568vw, 1472s1393s, 1348w,
1330vw, 1307m, 1287m, 1270vw, .1245m,
1181w, 1158m, 1135mw, 1113vw,
1090mw, 1048mw,1023m, 972vw, 920vw,
897vw, 830vw, 817vw, 765vs, 727w,
698mw, 679w, 655w, 645wm, 618vw,
512wm, 437vw
1490vw, 1330vw, 1312m, 1290sh, 1243m,
1212vw, 1165vw, 1158vw, 1095w, 890w,
796m, 760vs, 719m, 666vw, 643vw, 418w,
360vw, 350vw
1514m, 1493w, 1305m, 1288m, 1225m,
1204m, 1145w, 1108w, 1093w, 848sh,
842vs, 776w, 763m, 714vs, 695vw, 667w,
620vw, 590vw, 552vw, 515vw..,.. 440vw
1497vw, 1379s, 1348s, 1310m, 1283w,
1250vw, 1230m, 1207vw, 1167w, 1110w,
1100vw, 1075vw, 1063vw, 1048vw,
933vw, 885vw, 809w, 772vs, 756sh, 723s,
680vw, 672vw, 610w, 533vw, 427m
1490m, 1465s, 1448vs, 1241w, 1230vw,
1186m, 1167w, 1155w, 1082m, 1056s,
1023m, 998w, 930w, 897vw, 854vw,
760vs, 733vs, 718vs, 695vs, 670w,
642vw, 613vw, 537w, 468vw, 418w
1523m, 1347w, 1313s, 1262m, 1212w,
1102, 1045vw, 895w, 868vw, 798m,
744m, 701vw, 658m, 456m, 440w, 367w,
353m
1524w, 1508vw, 1469w, 1458’vw, 1385w,
13622?, 1318w, 1297w, 1245vw, 1230vw,
1202w, 1109m, 762w, 735w, 682m,
667vw, 460vw, 426vw
1594s, 1495m, 1445m, 1310vw, 1285vw,
1260vw, 1173m, 1140m, 1069w, 1023m,
997vw, 927w, 840m, 802vw, 722s, 708s,
689s, 520sh, 512m, 482m, 462w
The IR spectra of complexes with phenanthrolines showed that the carboxylates are
symmetrically bonded to the both rhodium atoms because differences between vas(coo) and
vs(coo) are small (Table 2).
In the H NMR spectra, chemical shifts of protons of carboxylato ligands in [Rh(RCOO)2(N-
N)2(H20)2]2+ are higher than those of non-coordinated carboxylates and RCOO groups in
Rh2(OOCR)4(H20)2 complexes.
The phenanthroline, 2,2’-bipyridine and 2,2’:6’,2"-terpyridine ligands in
[Rh2(OOCPh)(phen)2(H20)](OOCPh), [Rh2C 2(OOCR)(N-N)2 (R H, alkyl)[Rh2(OOCPr)
(bpy)(HO)2](E)OCPr2, [RhOOCBun)-(phen-)( O)2](oOCgunl2 [Rh2(OOCBun)2(bpy)2(H20)2]
(OOC-Bun) and [Rh2(O-OCCR3)(terpy)2C-12][H30]- 129H-20 are symmetrically bound 0 the rhodium 2. atoms. Ths s. proven by the presence only 4 signals of hydrogen atoms of heter,o,cyclic nitr,,ogen ligands in the 1H NMR spectra of phenanthroline complexes and signals of H5 + H5, H6 + H6 and
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multiplet for the other protons of 2,2’:6’,2"- terpyridine ligand in complex 9 (Table 3). The H NMR
spectrum of terpy complex is consistent with the X-ray structure of this compound [26]. However,
the H NMR spectra of complexes 1-4, and 13 consist of multiplets due to non-equivalent protons
of the nitrogen ligands. Thus, the nitrogen ligands are coordinated asymmetrically in complexes
containing chiral mandelato bridging groups and in acetato complex with dmpq. An unambiguous
assignment of the spectra was possible only for the compounds 2 and 3. In the case of complexes
1,4 and 13 most of the signals were overlapped and therefore they could not be unambiguously
assigned.
Table 3. H NMR Spectra of Rhodium(ll) Complexes.
Complex
1in
CD.OD
2 in D20
3 in g20
4 in D20
5 in D20
6 in D20
8in
CD.OD
8 in 020
9 in 020
10 in D20
11 in D20
12 in D20
13 in 920
14 in
CD3OD 14 n
.CDCI.
15 in
CDOD
151n
CDCI3
16 in
(CD.)CO
, ppm, (J, Hz)
3.334s(CH3), 4.598S(CHPhhc), 4.977s(CHPhc) ., 6.50-8.46m(Ph4-diMe-phen)
5.627s(CHC), 7.199dd(He, J7_8 8.28 Hz, J89 5.13 Hz), 7.25 7.32m(H3 +"phnc),
7.424d(H9), 7.507(H6, the AB spectrum, J56 8.90 Hz), 7.550(HS,the AB spectrum),
7.61 7.67m(HP, H, phc), 7.73- 7.77m(H%phc), 7.843d(H2, J23 5.13 Hz),
7.997d(H7), 8.134d(H4, J_ 8.13 Hz)
5.591s(CHC), 7.175dd(H8, J78 8.22 Hz, J89 5.13 Hz, J,.= 5.13 Hz), 7.255dd(H3,
J23 5.13 Hz, J34 8.22 Hz), 7.402d(Hg), 7.488(H6, the .B spectrum, Js,= 8.95 Hz),
536(H5,the AB spectrum), 7.59 7.65m(H, H, Ph), 7.70 7.73m(H), "7.821d(H2,
J_ 5.13 Hz), 7.976d(H7), 8.117d(H4)
1.80s(CH3COOnC), 2.43s (CH3COOC), 2.27s (OH3), 2.51s(CH3), 2.55s(CH3)
2.60s(CH), 6.75-8.60m(aromatic H)
7.346t(4H, Hl-phenylc, J,=7.2 Hz), 7.419m_(4H, H3,14a-2H, H-phenylC), 7.560t(4H,
H#-phenylno, J,1=7.6 Hz)"7.604s(4H, H5, He, phen), 7.685t(2H, H-phenylno, J,=7.4
Hz), 7.736d(4FI, H-phenylC), 8.153dd (_4H, _1--I4, H7, phen, J3_4=8.2 Hz, J24=0.8 R_),
8.349d(4H, H-phenylnc), 8.412d(4H, Hz, H9, phen, J2. 5.1 Hz)
1.592s(CH3), 1.616s(CH3), 1.677s(CH.), 1.704s(CH3), 1.784s(CH3),
1.799s(CH), 6.99- 7.15m(Ph), 7.22-7.35m(Ph)
7.391 (H5,J 5.5 Hz 7.2 Hz), 7.88 7.99m(H3 +4), 8.355t(HCOO JahH 4.2
Hz), 8.427cr(1--I6) J45
7.243m(HS), 7.74 7.82m(H3 + H4), 8.232d(H6, J56 5.’2 Hz), 8.240t(HCOO, JRhH
4.0 HZ)
2.72s(3H, CH.), 7.44ddd(4H, H5 + H 5’’, J35 1.4 Hz, J45 7.4 Hz, J56 5.3 Hz), 7.83
8.03m(14H), 8.13d(4H, H6 + H6’’)
nc 3 c 0.766t(6H, CH J(HH=7.40 Hz), 0.963t(6H, CH3 3JIHH=7.40 HZ), 1.428sxt(4H,
CHiCHi, ]J,,H,=7.40FI), 1.757sxt(4H, CHCH.c, JHHi- 7.40 HZ), 2.024t(4H,
C/"FCOO, 314=7.38 Hz), 2.676t (4H, CH2-CO0, 3_J;=7.38 Hz), 7.273ddd(4H,
4 4 6 6 HS,FI 5’, J56=5: Flz, Js=7.5 Hz), 7.75-7.85m (8H, H,’R’, H, H ’), 8.147d(4H, H, H ’)
0.754t(6H, CH3nc, 3JHH=7.40 HZ), 0.941t(6H, CH3C, 3JHH)=7.40 HZ), 1.161Sxt(4H,
CH#Menc, 3JaH=7.40 FtZ), 1.388qnt(4H, CH2Etnc), 1.43Sgxt(4H, CH2M.eC),
c Z Tc 3 1.816qnt(4H, CH_Et ), 2.042t(_;H, CH2COQ ), 7.490dd(4H, H, Ha, Jo=5.2 Hz),
5 6 4 7 Ja=8.2 Hz), 7.588s(4H, H H ), 8.153d(4H, H, H ), 8.342d(4H, H2,Hg
0.765t(6H, CH3nc, 3J(HH=7.35), 0.901t(6H, CH.c, 3,.J(&.lH)=7.35 HZ), 1.173sxt(4H,
CHCH.no, 3JH=7.35 HZ), 1.372Sxt(4H, CH2CH_3c, 33iHH)=7.35 HZ), 1.401qnt(4H,
C/--FEtn, 3J(H,=7.35 HZ), 1.724qnt(4H, CH2Etc, rJ(4H’---7-:48 Hz), 2.052t(4H,
C/-’coono;JIHH)=7.42 Hz), 2.702t(4H, CHCOOC, 3J,.H=7.45 Hz), 7.275ddd(4H,
3 3 4 4 H5,R5’, J56 H;:, 345=7.3 Hz, J36=1.8 Hz), 7.76-7.85m(8R,’ H H ’, H H ’), 8.141(4H,
H6, H6’)
c 5 5.50s(CHOH ), 6.97q(H ’, J5’6’ 5,6 Hz), 7.02q(H5, Js 5.6 Hz), 7.25d(H6’),
7.32m(phnc), 7.54 7.76m(Pldc + H3’+ H3 + H4’+ H4 + [.6)
0.728t(12H, CH3, 3j(HH) 7.30 Hz), 1.436sxt(8H, CH_2_e), 2.030t(8H, CH2CO0
0.770t(12H, CH3, 3j(HH) 7.30 Hz), 1.528sxt(8H, CH2Me), 2.262t(8H, C/--F2COO
0.793t(12H, CH3, 3j(’HH)= 7.30 Hz)’, 1.130sxt(8H, CH2Me), 1.394qnt (8H, CH2Et),
2.053(8H, CHCOO)
0.796t(12H, CT-I., 3j(HH) 7.30 Hz), 1743sxt(8H, CH2Me), 1.489qnt(8H, CH2Et),
2.288t(8H, CH2COO
7.28t(8H, HP, Jl JP 7.5 Hz), 7140t(4H, H), 7.87d(8H, Ha)
nc noncoordinating ion, c coordinating ligand, qnt quintet, sxt sextet
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The complexes 1-13 and the ligands (phen, drop, bpy, terpy and dmpq) were tested in
vitro for antibacterial activity against Gram-positive Staphylococcus aureus 209 P (Oxford) and Gram-
negative Escherichia coilROW strains (Table 4). The highest activity against Gram-positive bacteria
axhibited complexes 2-6 and 10-12. Compounds 1 and 7 are much less active against S. aureus
and all complexes show rather low activity against E. coil The complexes 2, 4, ,5 and 10-12 are
considerably more active than the appropriate nitrogen ligands. However, the activity of complex 1
is lower than that of drop. The activity of 3 is almost the same as that for non-coordinated phen and
lower than activity of 2. The complex 3 in the solid state contains chloro ligands coordinated along
the Rh Rh axis, however in solutions in water and in alcohols the prevailing form is
[Rh2CI{PhCH(OH)COO}2(phen)(H20)]+ [2]. This indicate that complexes containing aqua
molecules coordinated along Rh -Rh axis are more active than those with at least one chloro ligand
substituted for HO. This is also confirmed by low activity of complex 9 with two chloro ligands
bound along the Rh Rh axis [26]. In order to get more information about the nature of the inhibitory
activity of the investigated compounds, we have tested the survival of S. aureus in YP medium
containing different concentration of complexes 2, 4, ,5 and 6. Viable counts were determined
after 4 and 24 h and the results are presented in Fig. 2. All of the tested compounds delayed the
beginning of the exponential growth of bacteria and clear-cut decrease of viable count in overnight
cultures was observed at concentrations near to MIC. Values of viable count lower than the
inoculum size indicate that the compounds have bactericidal activity. Among the tested
compounds the most active is complex ,5.
It is known that the bactericidal activity of some antibiotics and chemoterapeutic agents
depend on the size of thepopulation of treated microorganisms. Therefore, we have determined
the survival of S. aureus cultures over the population range 10 to 106 cells/cm3 in the presence of
,5. The results presented in Table 5 indicate that the bactericidal activity of this compound depends
on inoculum size. The bacteria are killed at the lowest concentration of ,5 (6.107 M) when the
inoculum size is equal to or less than 10’ cells/cm3, however, for the populations equal to or greater
than 105 cells/cm3, the complex 5 is effective at the concentration 1.25.10-6 M.
Table 4. Minimal inhibitory concentration of rhodium compounds for
E. coilROW and S. aureus 209P Oxford*
Complex
Control
1
10
Concentration
[M]
0
1 10.5
1 10.6
1 10.4
5 10.5
10.5
5.10-6
1 10.4
5 10.5
1 10.5
1 10.4
1 10.5
1 10.4
10.5
10.4
1 10-5
1 10.4
1 10-5
1 10-4
5 10.5
1 10.5
1 10.4
10.5
1 10.4
1 10.5
E. coli
lb0
71.9
100
0
0
92.2
0
0
90.0
0
100
0
100
59.2
84.0
0
100
0
0
28.8
0
100
0
100
Percent of c.f.u.
S. aureus
100
71.7
100
0
0
0
0.02
24.0
0
0
0
87.0
86.5
77.9
0
0
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11
12
dmp
dmpq
phen
terpy
,bpy
10.4
5 105
2.5 105
1.10-5
5.10-6
1-106
10-4
5 10-5
2.5 10-5
1.10-5
5.10-6
1.10-6
1 ’1’0"4
5 10.5
10.5
.10_4
10-5
10-4
10.4
10-5
10.4
10.4
0
0
1
100
0
0
0.6
100
0
0
100
52
60
0
37
60
74
0
0
100
0
100
0
33
0
0
33
0
21
29
34
*determined on nutrient agar plates supplemented with tested rhodium complexes
not tested
Some of the antibacterial agents, e.g. penicillin, are active only against growing cells. Thefore, it was
interesting to find out whether the investigated compounds are active only against growing or also
resting cells. The dependence of the survival of S. aureus treated with compound ,5 on its
concentration and time is presented in Table 6. It is evident that the complex ,5 shows a killing effect
on cells unable to grow. Incubation in saline even without the rhodium complexes leads to a
decrease in viable count of S. aureus but in the presence of the compound 5 the diminution of the
percent of colony forming units is much more drastic and depends on concentration. Analogous
investigations were also carried out for complex 4.
E! 6.f.c./rnl at start
1 c.f.c, after 4 hrs of incubation
E! c.f.c./rnl after 24 hrs of incubation
concentration of complexes, mol 10
Fig. 2 Survival of S. Aureus P Oxford after 4 and 24 h exposition in YP broth treated with compounds
2, 4, 5 and 6 (c. f. c. colony forming cells)
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Table 5. The dependence of the activity of complex 5
on the inoculum size of S. aureus 209P Oxford in YP broth.
Cnentration
[M]
6.10-7
1.25.106
21’5.10.6
5.10-6
Time
[hi
4
24
4
24
’4
24
4
24
Viable count/cm3
"4.1.106
"5.3.107
2.0.108
<1.0.104<
104
’4.6.105
<5.105
3.8.106
2.6.105
4.1.105
5.0.105
3.6.108
3.4.105
<104
2.9.103
50
7.7.102
<10
4.1.104
<10
<10
1.2.102
<10
<10
<1o
<10
4.1.103
1.102
<10
2O
<10
<10
<10
<10
<10
4.1.102
<’10
<10
<10
<10
<10
<10
<10
<10
4.1.101
<’i0
<10
<10
<10
<10
<10
<’10
<10
Table 6. Survival of S. aureus in saline treated with compound 5.
Concentration
[M]
0
9.10-9
1.5.10"7
:"’.25.10-6
5.10-6
1.10.5
Time
[hi
0
2
4
24
2
4
24
2
4
24
2
4
24
2
4
24
2
4
24
Percent of survival
(No of colony u,nits/cm3).
100 (13.5o102
84
4.8
<0.1
82
13.5
<0.1
79
4.9
<0.1
71
<0.1
0
3O
<0.1
0
18
<0.1
0
1 O0 (4.79.104)
79
8.4
<0.1
93.5
3.5
<0.1
83.3
3.5
<0.1
46
<0.1
0
19
<0.1
0
15
<0.1
0
The results given in Table 7 indicate that compound 4 is also bactericide. This compound shows
bactericidal activity against nongrowing cells suspended in saline (Table 8). The activity of the
compound 5 was also tested against some of clinical S. aureus strains chosen at random. From
among of 19 strains only 1 was resistant to the complex ,5 in YP medium.
Table 7. Dependence of the survival of S. aureus on inoculum size and concentration
of complex 4 in YP broth.
Concentration Time
[M] [h]
0 0
4
24
3.2.106
4.5.107
1.9.108
3.2.105
9.2.105
1.7.108
Viable count/cm3
3.2.104
4.5.104
1.5.108
312.103
9.1.103
1.2.108
3.2.1,02
2.9.103
7.0.107
32
30
4.1 o107
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6.10-7
1.25-10"6
2.5.10-6
5.10-6
4
24
4
24
4
24
4
24
6.6.106
2.5.10
<1.0.106
<1.0.106
<1.0.106
<10
<1.0.106
<10
2.5.106
2.0.10
8.7.105
<1.0.105
5.3.105
<10
<2.7.104
<10
1.5.105
1.5.108
3.2.104
<1.0.105
6.5.103
<10
5.5.102
<10
6.8.103
8.6.107
4.4.103
1.1.104
3.9.i03
<10
3.2.102
<10
4.1.109
5.1.107
3.6.102
5.2.103
2.9.102
<10
<10
<10
9.0.107
4.6.107
85
1.5.103
60
80
<10
<10
Table 8. Survival of S. aureus 209P Oxford in saline
treated with compound 4
Concentration
[M]
0’
6.10-7
1.25.10-6
2.5.10.6
5.10-6
Time
[hi
0
4
24
4
24
4
24
4
24
4
24
Viable count/cm3
1.0.107
2.3.106
8.2.104
5.4.105
3.3.104
6.7.104
3.9.102
2.5.105
1.8.102
.’6.105
2.4.101
1.0.106
6.0.104
4.2.102
3.2.104
3.8.10
9.0.103
<10
4.8.102
<10
<10
<10
The most active antibacterial agents against S. aureus are carboxylato complexes with
ligands containing relatively bulky hydrocarbyl groups, i.e. C4H.COO-, CH.COO-and
CsH.CH(OH)COO-: [Rh{OOC(CH).CH.a}(phen)(HO)2]{OOC(CH2)3CH.}2 (11)[Flh2{OOC(CH2)3
CFI3}(bpy)(HO)]{OOC(CH2).aCI-].} (1)-, [Rh(OOCCsHs)2-(phen-)(H20-2](OOCCH5)2 (,5)and
[Rh9{-OOCCH(-OI-f)C6H.}(phen-)(HO)2]-{OOC-CH(OH)C6H-5}2 (2). Activity of [Rh2{OOCCH(OH
CsH-5}2(bpy)2(H20)2]-{-OOCCH(OH)C6-H5}2 (13), however, is [ower than that of complex 2.
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